Page last updated: 2024-10-30

metformin and Candidiasis

metformin has been researched along with Candidiasis in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
" Overall adverse event (AE) incidence over 52 weeks was 69."2.79Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone. ( Forst, T; Goldenberg, R; Guthrie, R; Meininger, G; Stein, P; Vijapurkar, U; Yee, J, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Brandi, P1
Conejero, L1
Cueto, FJ1
Martínez-Cano, S1
Dunphy, G1
Gómez, MJ1
Relaño, C1
Saz-Leal, P1
Enamorado, M1
Quintas, A1
Dopazo, A1
Amores-Iniesta, J1
Del Fresno, C1
Nistal-Villán, E1
Ardavín, C1
Nieto, A1
Casanovas, M1
Subiza, JL1
Sancho, D1
Forst, T1
Guthrie, R1
Goldenberg, R1
Yee, J1
Vijapurkar, U1
Meininger, G1
Stein, P1

Trials

1 trial available for metformin and Candidiasis

ArticleYear
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.
    Diabetes, obesity & metabolism, 2014, Volume: 16, Issue:5

    Topics: Blood Glucose; Blood Pressure; Canagliflozin; Candidiasis; Diabetes Mellitus, Type 2; Diuretics, Osm

2014

Other Studies

1 other study available for metformin and Candidiasis

ArticleYear
Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
    Cell reports, 2022, 01-04, Volume: 38, Issue:1

    Topics: Administration, Intranasal; Animals; Antibodies, Viral; Bacteria; Bacterial Vaccines; Candidiasis; C

2022